GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 1301 - 1325 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▲ Arbitrary Fluorescence Units (AFU)
IgA Patient 2 24 mild
G25559RS
2725
IgG Patient 2 15 mild
G25559RS
1605
IgG Patient 2 24 mild
G25559RS
2133
IgM Patient 2 15 mild
G25559RS
3083
IgM Patient 2 24 mild
G25559RS
5565
IgA Patient 2 3 mild
G25559RS
1082
IgG Patient 2 3 mild
G25559RS
1635
IgM Patient 2 3 mild
G25559RS
639
IgA Patient 3 -180 mild
G25559RS
350
IgA Patient 3 11 mild
G25559RS
1141
IgG Patient 3 -180 mild
G25559RS
126
IgM Patient 3 -180 mild
G25559RS
111
IgA Patient 3 4 mild
G25559RS
1127
IgG Patient 3 11 mild
G25559RS
298
IgG Patient 3 4 mild
G25559RS
275
IgM Patient 3 11 mild
G25559RS
164
IgM Patient 3 4 mild
G25559RS
158
IgA Patient 4 12 mild
G25559RS
2374
IgG Patient 4 12 mild
G25559RS
857
IgM Patient 4 12 mild
G25559RS
829
IgA Patient 1 10 moderate
G26125KY
435
IgA Patient 1 22 moderate
G26125KY
432
IgA Patient 1 6 moderate
G26125KY
444
IgG Patient 1 10 moderate
G26125KY
113
IgG Patient 1 22 moderate
G26125KY
114

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024